Increasing evidence supports that metabolic inflammation is a consequence of obesity and it may play, in turn, a causative role in blunting insulin sensitivity and disrupting metabolic/energy homeostasis [1,2]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.